Medicare Enrolled

Dr. Anita Kiehl, MD

Infectious Disease · Albany, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
404 NEW SCOTLAND AVE., Albany, NY 12208
5184350662
In practice since 2006 (19 years)
NPI: 1487744116 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kiehl from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kiehl? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kiehl

Dr. Anita Kiehl is an infectious disease specialist in Albany, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kiehl performed 202 Medicare services across 145 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kiehl received a total of $6,703 from 25 pharmaceutical and/or device companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kiehl is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 202 Medicare services $6,703 industry payments

Medicare Practice Summary

Medicare Utilization ↗
202
Medicare services
Bottom 38% in NY for infectious disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
145
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
103 $93 $189
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
57 $136 $397
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
24 $62 $140
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $89 $220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,703
Total received (2018-2024)
Avg $958/year across 7 years
Top 14% in NY for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,568 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$135 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$887
2023
$862
2022
$497
2021
$754
2020
$1,202
2019
$1,383
2018
$1,119

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$446
Gilead Sciences, Inc.
$118
Merck Sharp & Dohme LLC
$70
ABBVIE INC.
$69
Theratechnologies Inc.
$50
Insmed, Inc.
$49
Astellas Pharma US Inc
$35
Shionogi Inc
$27
EMD Serono, Inc.
$23
Top 3 companies account for 71.5% of 2024 payments
All-time payments by company (2018-2024) ›
ViiV Healthcare Company
$1,908
Merck Sharp & Dohme Corporation
$1,174
Gilead Sciences, Inc.
$701
Astellas Pharma US Inc
$458
Janssen Biotech, Inc.
$450
Allergan Inc.
$313
Theratechnologies Inc.
$206
Shionogi Inc
$191
Insmed, Inc.
$176
Merck Sharp & Dohme LLC
$159
ABBVIE INC.
$155
Melinta Therapeutics, Inc.
$120
Paratek Pharmaceuticals, Inc.
$109
Allergan, Inc.
$98
EMD Serono, Inc.
$86
AbbVie Inc.
$82
Nabriva Therapeutics, plc
$65
Ferring Pharmaceuticals Inc.
$55
Janssen Scientific Affairs, LLC
$55
Theravance Biopharma, Inc.
$49
Vyera Pharmaceuticals, LLC
$22
Shire North American Group Inc
$21
Melinta Therapeutics, LLC
$19
TETRAPHASE PHARMACEUTICALS, INC.
$17
Oxford Immunotec USA Inc
$12
Top 3 companies account for 56.4% of all-time payments
Associated products mentioned in payments ›
AMBISOME · APRETUDE · AVYCAZ · Arikayce · CABENUVA · CRESEMBA · CUVITRU · Cresemba · DALVANCE · DELSTRIGO · DIFICID · DOVATO · Daraprim Tablet 25mg · EGRIFTA · Fetroja · ISENTRESS · JULUCA · MYCAMINE · NOXAFIL · NUZYRA · Orbactiv · PIFELTRO · PREZCOBIX · REBYOTA · RUKOBIA · SEROSTIM · SYMTUZA · Serostim · Symtuza · TEFLARO · TRIUMEQ · TROGARZO · TSPOT TB TEST · VIBATIV · Vabomere · Xenleta · Xerava · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an infectious disease specialist in Albany?
Compare infectious diseases in the Albany area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
25
Per 100K population
7.9
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kiehl is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kiehl experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Kiehl performed 103 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kiehl receive payments from pharmaceutical companies?
Yes. Dr. Kiehl received a total of $6,703 from 25 companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kiehl's costs compare to other infectious diseases in Albany?
Dr. Kiehl's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kiehl) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →